View of THE PLACE OF SGLT2 INHIBITORS AND L-CARNITINE IN THE TREATMENT OF PATIENTS WITH STEMI ON THE BACKGROUND OF TYPE 2 DIABETES

Return to Article Details THE PLACE OF SGLT2 INHIBITORS AND L-CARNITINE IN THE TREATMENT OF PATIENTS WITH STEMI ON THE BACKGROUND OF TYPE 2 DIABETES Download Download PDF